A Search for Dual Action HIV-1 Reverse Transcriptase, Bacterial RNA Polymerase Inhibitors. 2017

Agata Paneth, and Tomasz Frączek, and Agnieszka Grzegorczyk, and Dominika Janowska, and Anna Malm, and Piotr Paneth
Department of Organic Chemistry, Medical University of Lublin, 20-093 Lublin, Poland. agata.paneth@umlub.pl.

Using molecular modeling approach, potential antibacterial agents with triazole core were proposed. A moderate to weak level of antibacterial activity in most of the compounds have been observed, with best minimal inhibitory concentration (MIC) value of 0.003 mg/mL, as shown by the 15 against S. epidermidis. Studied compounds were also submitted to the antifungal assay. The best antifungal activity was detected for 16 with MIC at 0.125 and 0.25 mg/mL against C. albicans and C. parapsilosis, respectively.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D000074429 Candida parapsilosis A species of MITOSPORIC FUNGI and opportunistic pathogen associated with its ability to form BIOFILMS in catheters and parenteral nutrition IV lines. C. parapsilosis complex includes closely related species C. orthopsilosis; and C. metapsilosis. Mycocandida parapsilosis,Mycotorula parapsilopsis,C. metapsilosis,C. orthopsilosis,C. parapsilosis,C. parapsilosis Complex,Candida metapsilosis,Candida orthopsilosis,Candida parapsilosis Complex,Candida parapsilosis Group
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D012321 DNA-Directed RNA Polymerases Enzymes that catalyze DNA template-directed extension of the 3'-end of an RNA strand one nucleotide at a time. They can initiate a chain de novo. In eukaryotes, three forms of the enzyme have been distinguished on the basis of sensitivity to alpha-amanitin, and the type of RNA synthesized. (From Enzyme Nomenclature, 1992). DNA-Dependent RNA Polymerases,RNA Polymerases,Transcriptases,DNA-Directed RNA Polymerase,RNA Polymerase,Transcriptase,DNA Dependent RNA Polymerases,DNA Directed RNA Polymerase,DNA Directed RNA Polymerases,Polymerase, DNA-Directed RNA,Polymerase, RNA,Polymerases, DNA-Dependent RNA,Polymerases, DNA-Directed RNA,Polymerases, RNA,RNA Polymerase, DNA-Directed,RNA Polymerases, DNA-Dependent,RNA Polymerases, DNA-Directed
D013212 Staphylococcus epidermidis A species of STAPHYLOCOCCUS that is a spherical, non-motile, gram-positive, chemoorganotrophic, facultative anaerobe. Mainly found on the skin and mucous membrane of warm-blooded animals, it can be primary pathogen or secondary invader.

Related Publications

Agata Paneth, and Tomasz Frączek, and Agnieszka Grzegorczyk, and Dominika Janowska, and Anna Malm, and Piotr Paneth
January 2002, Acta poloniae pharmaceutica,
Agata Paneth, and Tomasz Frączek, and Agnieszka Grzegorczyk, and Dominika Janowska, and Anna Malm, and Piotr Paneth
June 2007, Applied microbiology and biotechnology,
Agata Paneth, and Tomasz Frączek, and Agnieszka Grzegorczyk, and Dominika Janowska, and Anna Malm, and Piotr Paneth
December 1992, Journal of virological methods,
Agata Paneth, and Tomasz Frączek, and Agnieszka Grzegorczyk, and Dominika Janowska, and Anna Malm, and Piotr Paneth
January 2008, Advances in pharmacology (San Diego, Calif.),
Agata Paneth, and Tomasz Frączek, and Agnieszka Grzegorczyk, and Dominika Janowska, and Anna Malm, and Piotr Paneth
June 2008, Virus research,
Agata Paneth, and Tomasz Frączek, and Agnieszka Grzegorczyk, and Dominika Janowska, and Anna Malm, and Piotr Paneth
January 2000, Advances in pharmacology (San Diego, Calif.),
Agata Paneth, and Tomasz Frączek, and Agnieszka Grzegorczyk, and Dominika Janowska, and Anna Malm, and Piotr Paneth
January 1992, Journal of enzyme inhibition,
Agata Paneth, and Tomasz Frączek, and Agnieszka Grzegorczyk, and Dominika Janowska, and Anna Malm, and Piotr Paneth
December 2017, Journal of enzyme inhibition and medicinal chemistry,
Agata Paneth, and Tomasz Frączek, and Agnieszka Grzegorczyk, and Dominika Janowska, and Anna Malm, and Piotr Paneth
June 2018, Expert opinion on emerging drugs,
Agata Paneth, and Tomasz Frączek, and Agnieszka Grzegorczyk, and Dominika Janowska, and Anna Malm, and Piotr Paneth
March 2023, European journal of medicinal chemistry,
Copied contents to your clipboard!